[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  C&EN (Chemical & Engineering News) [@cenmag](/creator/twitter/cenmag) on x 125.4K followers Created: 2025-06-13 18:30:20 UTC Radiopharmaceutical company RayzeBio, a wholly owned subsidiary of Bristol Myers Squibb, will license a therapeutic and diagnostic asset for prostate cancer from Philochem. XXXXX engagements  **Related Topics** [$ryzb](/topic/$ryzb) [$bmy](/topic/$bmy) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/cenmag/status/1933592793072488456)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
C&EN (Chemical & Engineering News) @cenmag on x 125.4K followers
Created: 2025-06-13 18:30:20 UTC
Radiopharmaceutical company RayzeBio, a wholly owned subsidiary of Bristol Myers Squibb, will license a therapeutic and diagnostic asset for prostate cancer from Philochem.
XXXXX engagements
Related Topics $ryzb $bmy stocks healthcare
/post/tweet::1933592793072488456